Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05436548 · ClinicalTrials.gov registry record · NA
The Work-life Check-ins: a Supervisor-driven Intervention to Reduce Burnout in Primary Care
A NA study of Burnout, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT05436548: Recruiting NA study of Burnout, sponsored by Oregon Health and Science University.
NCT05436548 is a NA study of Burnout that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 500 participants, below the 5,131-participant average among 18 other Burnout trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05436548, a NA study of Burnout, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this study is to evaluate the effectiveness and process of frequent supervisor-employee check-ins in reducing burnout among employees of primary care clinics in Portland, OR. Healthcare workers are at risk for burnout and associated adverse health and safety outcomes, including chronic diseases and occupational injuries. Not only does burnout affect healthcare workers, but burnout also affects the quality of patient care. The proposed study will create a check-in process between supervisors and healthcare workers, which addresses supervisor support, awareness of services and resources, and work-life balance. The Work-life Check-ins project expects to see reduced burnout among employees participating in the check-ins intervention compared to those in the control group.
Conditions Studied
Interventions
- OTHER Supervisor-employee frequent check-ins to identify and address work stressors
- OTHER Usual practice waitlist controls
Study Locations (2)
Oregon
- OHSU - Portland
- OHSU - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-01-03 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT05436548 shows while recruiting
NCT05436548 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 5,131-participant average among 18 other Burnout trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Burnout appearing as the primary indexed condition, and to 2 interventions - of which Supervisor-employee frequent check-ins to identify and address work stressors is the first listed.
NCT05436548 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05436548 about?
NCT05436548 is a clinical study titled "The Work-life Check-ins: a Supervisor-driven Intervention to Reduce Burnout in Primary Care". The objective of this study is to evaluate the effectiveness and process of frequent supervisor-employee check-ins in reducing burnout among employees of primary care clinics in Portland, OR. Healthcare workers are at risk for burnout and associated adverse health and safety outcomes, including chro...
What is the current status of trial NCT05436548?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-01-03. Estimated completion is 2026-08-31.
What conditions does trial NCT05436548 study?
This clinical trial studies the following conditions: Burnout.
What interventions are being tested in trial NCT05436548?
The interventions under investigation include: Supervisor-employee frequent check-ins to identify and address work stressors (OTHER), Usual practice waitlist controls (OTHER).
Who is sponsoring clinical trial NCT05436548?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05436548 being conducted?
This trial has 2 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burnout
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05436548's enrollment target sits among peer trials
500 4th of 18 higher than 15 of 18 other Burnout trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Burnout trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Keck Medicine of University of Southern California Thrive Study
RECRUITING · NA
-
Vital Coach: A Study of Resiliency in Medical Students
RECRUITING · NA
-
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
RECRUITING · NA
-
Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST)
RECRUITING · NA
-
Feasibility of Virtual Tai Chi Easy for Registered Nurses
RECRUITING · NA
-
A Pilot Study of RISE for Nurse Managers Retreat
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI